Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 21, 2021

SELL
$57.98 - $96.6 $51,602 - $85,974
-890 Closed
0 $0
Q1 2021

Apr 05, 2021

BUY
$71.56 - $121.23 $429 - $727
6 Added 0.68%
890 $68,000
Q4 2020

Jan 20, 2021

BUY
$47.41 - $115.03 $25,079 - $60,850
529 Added 149.01%
884 $78,000
Q3 2020

Oct 19, 2020

BUY
$43.0 - $84.01 $15,265 - $29,823
355 New
355 $26,000

Others Institutions Holding IGMS

About IGM Biosciences, Inc.


  • Ticker IGMS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,969,000
  • Market Cap $500M
  • Description
  • IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...
More about IGMS
Track This Portfolio

Track Pacer Advisors, Inc. Portfolio

Follow Pacer Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.